Atherosclerosis and Hyperlipoproteinaemia
- 279 Downloads
Coronary heart disease (CHD) remains the leading cause of death in many countries. The fact that it may be declining in some areas (e.g. United States, Australia) allows no grounds for complacency. It is estimated that still more than 1.25 million Americans suffer a heart attack each year (Levy 1981), and in Scotland in 1977 the death rate from coronary disease was 800 per 100 000 population.
KeywordsBile Acid Nicotinic Acid Familial Hypercholesterolaemia Lipid Research Clinic Clinic Coronary Primary Prevention Trial
Unable to display preview. Download preview PDF.
- Editorial (1975) Lipids and ischaemic heart disease. Lancet II: 398Google Scholar
- Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 272Google Scholar
- Levy RI (1981) Lipoproteins, apoproteins and heart disease. Present status and future prospects. Clin Chem Acta 27: 653Google Scholar
- Murray RG, Tweddel A, Third JLHC, Hillis WS, Hutton I, Lorimer AR, Lawrie TDV (1975) Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J 37: 1035Google Scholar
- WHO European Collaborative Group (1983) Multifactorial trial in the prevention of coronary heart disease. 3. Incidence and mortality results. Eur Heart J 4: 141–147Google Scholar